vs

Side-by-side financial comparison of NEOGENOMICS INC (NEO) and ONESPAWORLD HOLDINGS Ltd (OSW). Click either name above to swap in a different company.

ONESPAWORLD HOLDINGS Ltd is the larger business by last-quarter revenue ($242.1M vs $186.7M, roughly 1.3× NEOGENOMICS INC). ONESPAWORLD HOLDINGS Ltd runs the higher net margin — 5.0% vs -57.9%, a 62.8% gap on every dollar of revenue. On growth, ONESPAWORLD HOLDINGS Ltd posted the faster year-over-year revenue change (11.5% vs 11.1%). Over the past eight quarters, ONESPAWORLD HOLDINGS Ltd's revenue compounded faster (7.1% CAGR vs 6.5%).

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

NEO vs OSW — Head-to-Head

Bigger by revenue
OSW
OSW
1.3× larger
OSW
$242.1M
$186.7M
NEO
Growing faster (revenue YoY)
OSW
OSW
+0.4% gap
OSW
11.5%
11.1%
NEO
Higher net margin
OSW
OSW
62.8% more per $
OSW
5.0%
-57.9%
NEO
Faster 2-yr revenue CAGR
OSW
OSW
Annualised
OSW
7.1%
6.5%
NEO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
NEO
NEO
OSW
OSW
Revenue
$186.7M
$242.1M
Net Profit
$-108.0M
$12.1M
Gross Margin
43.3%
Operating Margin
46.9%
6.8%
Net Margin
-57.9%
5.0%
Revenue YoY
11.1%
11.5%
Net Profit YoY
42.0%
-16.2%
EPS (diluted)
$-0.13
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NEO
NEO
OSW
OSW
Q1 26
$186.7M
Q4 25
$190.2M
$242.1M
Q3 25
$187.8M
$258.5M
Q2 25
$181.3M
$240.7M
Q1 25
$168.0M
$219.6M
Q4 24
$172.0M
$217.2M
Q3 24
$167.8M
$241.7M
Q2 24
$164.5M
$224.9M
Net Profit
NEO
NEO
OSW
OSW
Q1 26
$-108.0M
Q4 25
$12.1M
Q3 25
$-27.1M
$24.3M
Q2 25
$-45.1M
$19.9M
Q1 25
$-25.9M
$15.3M
Q4 24
$14.4M
Q3 24
$-17.7M
$21.6M
Q2 24
$-18.6M
$15.8M
Gross Margin
NEO
NEO
OSW
OSW
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
NEO
NEO
OSW
OSW
Q1 26
46.9%
Q4 25
-7.1%
6.8%
Q3 25
-14.4%
10.2%
Q2 25
-26.3%
9.2%
Q1 25
-16.6%
7.7%
Q4 24
-10.7%
7.9%
Q3 24
-12.6%
10.3%
Q2 24
-13.3%
8.4%
Net Margin
NEO
NEO
OSW
OSW
Q1 26
-57.9%
Q4 25
5.0%
Q3 25
-14.4%
9.4%
Q2 25
-24.9%
8.3%
Q1 25
-15.4%
7.0%
Q4 24
6.6%
Q3 24
-10.5%
8.9%
Q2 24
-11.3%
7.0%
EPS (diluted)
NEO
NEO
OSW
OSW
Q1 26
$-0.13
Q4 25
$0.12
Q3 25
$0.23
Q2 25
$0.19
Q1 25
$0.15
Q4 24
$0.13
Q3 24
$0.20
Q2 24
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NEO
NEO
OSW
OSW
Cash + ST InvestmentsLiquidity on hand
$146.1M
$16.3M
Total DebtLower is stronger
$84.0M
Stockholders' EquityBook value
$828.8M
$542.6M
Total Assets
$1.3B
$707.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NEO
NEO
OSW
OSW
Q1 26
$146.1M
Q4 25
$159.6M
$16.3M
Q3 25
$164.1M
$29.6M
Q2 25
$154.7M
$35.0M
Q1 25
$346.2M
$22.6M
Q4 24
$367.0M
$57.4M
Q3 24
$362.0M
$48.8M
Q2 24
$355.1M
$62.5M
Total Debt
NEO
NEO
OSW
OSW
Q1 26
Q4 25
$341.9M
$84.0M
Q3 25
$85.2M
Q2 25
$96.2M
Q1 25
$97.4M
Q4 24
$541.1M
$98.6M
Q3 24
$98.7M
Q2 24
$123.8M
Stockholders' Equity
NEO
NEO
OSW
OSW
Q1 26
$828.8M
Q4 25
$836.6M
$542.6M
Q3 25
$838.3M
$552.8M
Q2 25
$854.0M
$548.3M
Q1 25
$888.3M
$530.6M
Q4 24
$902.3M
$554.5M
Q3 24
$908.2M
$540.1M
Q2 24
$915.9M
$532.7M
Total Assets
NEO
NEO
OSW
OSW
Q1 26
$1.3B
Q4 25
$1.4B
$707.1M
Q3 25
$1.4B
$732.6M
Q2 25
$1.4B
$731.8M
Q1 25
$1.6B
$708.7M
Q4 24
$1.6B
$746.4M
Q3 24
$1.6B
$734.0M
Q2 24
$1.6B
$756.8M
Debt / Equity
NEO
NEO
OSW
OSW
Q1 26
Q4 25
0.41×
0.15×
Q3 25
0.15×
Q2 25
0.18×
Q1 25
0.18×
Q4 24
0.60×
0.18×
Q3 24
0.18×
Q2 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NEO
NEO
OSW
OSW
Operating Cash FlowLast quarter
$-8.1M
$20.0M
Free Cash FlowOCF − Capex
$14.9M
FCF MarginFCF / Revenue
6.2%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$68.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NEO
NEO
OSW
OSW
Q1 26
$-8.1M
Q4 25
$1.3M
$20.0M
Q3 25
$8.9M
$33.2M
Q2 25
$20.3M
$20.3M
Q1 25
$-25.3M
$10.1M
Q4 24
$9.8M
$16.6M
Q3 24
$9.2M
$28.6M
Q2 24
$13.9M
$18.7M
Free Cash Flow
NEO
NEO
OSW
OSW
Q1 26
Q4 25
$-6.5M
$14.9M
Q3 25
$570.0K
$27.6M
Q2 25
$14.0M
$17.6M
Q1 25
$-29.8M
$8.4M
Q4 24
$-1.8M
$13.2M
Q3 24
$-1.6M
$27.5M
Q2 24
$814.0K
$17.6M
FCF Margin
NEO
NEO
OSW
OSW
Q1 26
Q4 25
-3.4%
6.2%
Q3 25
0.3%
10.7%
Q2 25
7.7%
7.3%
Q1 25
-17.8%
3.8%
Q4 24
-1.0%
6.1%
Q3 24
-0.9%
11.4%
Q2 24
0.5%
7.8%
Capex Intensity
NEO
NEO
OSW
OSW
Q1 26
Q4 25
4.1%
2.1%
Q3 25
4.4%
2.2%
Q2 25
3.5%
1.1%
Q1 25
2.7%
0.8%
Q4 24
6.7%
1.5%
Q3 24
6.4%
0.5%
Q2 24
8.0%
0.5%
Cash Conversion
NEO
NEO
OSW
OSW
Q1 26
Q4 25
1.65×
Q3 25
1.36×
Q2 25
1.02×
Q1 25
0.66×
Q4 24
1.15×
Q3 24
1.33×
Q2 24
1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NEO
NEO

Segment breakdown not available.

OSW
OSW

Services$197.3M82%
Products$44.8M18%

Related Comparisons